ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 917

$835K Total Retail Price of All Prescriptions

Rank: 26 out of 917

507 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 507 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,374 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LEVOTHYROXINE SODIUM 460 361 1 3
SIMVASTATIN 430 322 2 2
OMEPRAZOLE 408 289 3 4
LISINOPRIL 365 260 4 1
AMLODIPINE BESYLATE 303 263 5 5
GABAPENTIN 210 106 6 17
HYDROCODONE-ACETAMINOPHEN 206 107 S3 7 6
TRAMADOL HCL 199 109 8 28
CYMBALTA 196 110 9 56
FUROSEMIDE 196 144 9 7
CITALOPRAM HBR 194 160 11 15
HYDROCHLOROTHIAZIDE 183 141 12 9
METFORMIN HCL 180 104 13 8
CARVEDILOL 161 121 14 33
METOPROLOL TARTRATE 155 148 15 11
POTASSIUM CHLORIDE 153 101 16 16
CRESTOR 148 111 17 30
LOSARTAN POTASSIUM 146 132 18 13
METOPROLOL SUCCINATE 129 115 19 18
TRAZODONE HCL 122 43 20 22
PANTOPRAZOLE SODIUM 120 65 21 44
SPIRIVA 120 61 21 45
SERTRALINE HCL 115 84 23 24
TRIAMTERENE-HCTZ 111 86 24 36
DIOVAN 102 77 25 49
ATORVASTATIN CALCIUM 98 59 26 14
ZOLPIDEM TARTRATE 91 77 27 21
NAMENDA 83 83 28 43
PROAIR HFA 83 46 28 35
ALENDRONATE SODIUM 83 79 28 23
NEXIUM 77 61 31 60
SYNTHROID 76 74 32 68
RANITIDINE HCL 75 40 33 29
WARFARIN SODIUM 71 24 34 10
LANTUS SOLOSTAR 70 21 35 63
MORPHINE SULFATE ER 68 22 S2 36 48
LOVASTATIN 67 54 37 19
MIRTAZAPINE 66 47 38 39
ATENOLOL 66 62 38 12
FENTANYL 66 32 S2 38 58
ADVAIR DISKUS 64 41 41 47
METHOCARBAMOL 63 31 R 42 87
DOXEPIN HCL 62 32 43 224
ROPINIROLE HCL 58 30 44 88
BUPROPION HCL SR 58 28 44 101
PRAVASTATIN SODIUM 57 40 46 20
OXYCODONE HCL 55 31 S2 47 27
NORTRIPTYLINE HCL 53 22 48 136
ALLOPURINOL 52 48 49 31
ABILIFY 51 19 50 172
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 36 51 42
METHADONE HCL 50 19 S2 51 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.